2024 (81 POSTS)
Wilson KP, Valazza E, Price C. 2024. Video modeling to support social communication goals of autistic adults: A tutorial. Am J Speech Lang Pathol 33(5):2249–2265; doi: 10.1044/2024_AJSLP-23-00479 .
View Abstract
Topics: evidence-based reviews , modeling
Monticello TM , Potter DM, Huang Q, Hart TK, Shuey D, Troth S, Vergis JM, Tassew N, et al. 2024. Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ Consortium longer duration nonclinical to clinical translational database. Toxicol Appl Pharmacol 492(Sept 5):117087; doi: 10.1016/j.taap.2024.117087 .
View Abstract
Topics: nonclinical safety assessment
Perry CS , Verwiel AH , Covington TR , Proctor DM . 2024. PBPK modeling demonstrates that exposure time adjustment is unnecessary for setting an acute manganese inhalation exposure guideline. Regul Toxicol Pharmacol 153(Nov):105698; doi: 10.1016/j.yrtph.2024.105698 . PMID: 39251127.
View Abstract
Topics: Air Quality , Manganese , modeling , PBPK/PBDE
Patlewicz G , Judson RS, Williams AJ, Butler T, Barone Jr. S, Carstens K, Cowden J, Dawson JD, et al. 2024. Development of chemical categories for per- and polyfluoroalkyl substances (PFAS) and the proof-of-concept approach to the identification of potential candidates for tiered toxicological testing and human health assessment. Comput Toxicol 131(Sep 1):100327; doi: 10.1016/j.comtox.2024.100327 . PMID: 40547594.
View Abstract
Topics: PFAS
Gawehn E, Greene N , Miljković F, Obrezanova O, Subramanian V, Trapotsi M, Winiwarter S. 2024. Perspectives on the use of machine learning for ADME prediction at AstraZeneca. Xenobiotica 54(7):368-378; doi: 10.1080/00498254.2024.2352598 .
View Abstract
Topics: pharmacokinetics
Reynolds JI , Choi J, Johnson BP. 2024. Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation. Curr Res Toxicol 7(Aug 8):100191; doi: 10.1016/j.crtox.2024.100191 . PMID: 39205829.
View Abstract
Topics: Adverse outcome pathways (AOPs) , risk assessment
Barker TH, McBride GM, Dias M, Price C , Munn Z. 2024. Contextual factors and G6PD diagnostic testing: A scoping review and evidence and gap map. Malaria J 23(1):241; doi: 10.1186/s12936-024-05050-6 .
View Abstract
Topics: malaria , scoping review
Jackson JW, Frederick C Streich Jr, Pal A, Coricor G, Boston C, …, Wood M , et al. 2024. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Sci Signal 17(844):eadn6052; doi: 10.1126/scisignal.adn6052 . PMID: 38980922.
View Abstract
Topics: drug development
Pollock D, Bailey HD, Hasanoff S, Munn Z, Valenzuela C, Stern C, Price C, et al . 2024. First Nations Peoples’ perceptions, knowledge and beliefs regarding stillbirth prevention and bereavement practices: A mixed methods systematic review. Women Birth 37(4):101604; doi: 10.1016/j.wombi.2024.101604 .
View Abstract
Topics: Systematic Review
Wingrat J, Price C , Wright T. 2024. Facilitators of and barriers to caregiver adherence to home therapy recommendations for infants and children with neuromotor and neuromuscular diagnoses: A scoping review. Am J Occup Ther 78(5):7805205070; doi: 10.5014/ajot.2024.050567 .
View Abstract
Topics: scoping review
Bean K, Jones SA, Chakrapani A, Vijay S, Wu T, Church H, … Jensen I , et al. 2024. Exploring the cost-effectiveness of newborn screening for metachromatic leukodystrophy (MLD) in the UK. Int J Neonatal Screen 10(3):45; doi: 10.3390/ijns10030045 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Rudisill C, Jacobs M, Roy M, Brown L , Eaton R, Malloy T, Davies H, Tickner JT. 2024. The use of alternatives assessment in chemicals management policies: Needs for greater impact. Integr Environ Assess Manag 20(4):1035-1045; doi: 10.1002/ieam.4826 . PMID: 37658263.
View Abstract
Topics: regulatory toxicology , risk assessment
Thompson CM , Dewhurst N, Moundous D, Borghoff SJ , Haws LC , Vasquez MZ. 2024. Assessment of the genotoxicity of tert-butyl alcohol in an in vivo thyroid comet assay. Environ Mol Mutagen 65(3–4):129–136; doi: 10.1002/em.22601 . PMID: 38717101.
View Abstract
Topics: genotoxicity
Lin HC, Sakolish C, Moyer HL , Carmichael PL, Baltazar MT, Ferguson SS, Stanko JP, Hewitt P, et al. 2024. An in vitro-in silico workflow for predicting renal clearance of PFAS. Toxicol Appl Pharmacol 489(Aug):117015; doi: 10.1016/j.taap.2024.117015 . PMID: 38917890.
View Abstract
Topics: PFAS
Mathisen GH, Bearth A, Jones LB, Hoffmann S, Vist GE, Ames HM,… Wikoff D , Wright F, Whaley P. 2024. Editorial: Time for CHANGE: System-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Arch Toxicol 98(8):2299-2308; doi: 10.1007/s00204-024-03802-6 . PMID: 38877155.
View Abstract
Topics: regulatory toxicology
Chew DS, Sacks NC , Emden MR, Cyr PL , Sherwood R, Pokorney SD. 2024. Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study. Int J Cardiol 403(May 15):131831; doi: 10.1016/j.ijcard.2024.131831 . PMID: 38331201.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr PL , Sawyer EK, Stephen CD, et al. 2024. Burden of illness and mortality in men with adrenomyeloneuropathy: A retrospective cohort study. Orph J Rare Dis 19(1):270; doi: 10.1186/s13023-024-0326-w . PMID: 39020416.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Van Herwerden D, Kant E, Jackson M, Fender C L, Garcia-Jaramillo M, O’Brien J, Thomas K, Samanipour S. 2024. Modular open-access and open-source Julia language toolbox for processing of HRMS data: jHRMSToolbox. ChemRxiv; doi: 10.26434/chemrxiv-2024-b713v . Under revision in Environ Sci Technol.
View Abstract
Topics: computational toxicology
Kenyon MO, Martin M, Martin EA, Brandstetter S, Wegesser T, Greene N , Harvey J. 2024. Deriving acceptable limits for non-mutagenic impurities in medicinal products–Durational adjustments. Regul Toxicol Pharmacol 150(June):105644; doi: 10.1016/j.yrtph.2024.105644 . PMID: 38761968.
View Abstract
Topics: NAMs
Patlewicz G , Karamertzanis P, Paul-Friedman K, Sannicola M, Shah I. 2024. A systematic analysis of read-across within REACH registration dossiers. Comput Toxicol 30(June):100304; doi: 10.1016/j.comtox.2024.100304 . PMID: 38993812.
View Abstract